About ETS translocation variant 5
ETS translocation variant 5 (ETV5) is a protein
from Homo sapiens identified by UniProt accession
P41161, 510 residues long.
MolForge cross-references it against 0 known binders and
510 disease associations.
Target properties
| Protein name | ETS translocation variant 5 |
| UniProt accession | P41161 |
| Gene | ETV5 |
| Organism | Homo sapiens |
| Length | 510 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (510)
Diseases linked to this target (Open Targets).
- body mass index · score 0.49
- high density lipoprotein cholesterol measurement · score 0.48
- glomerular filtration rate · score 0.45
- physical activity measurement · score 0.45
- creatinine measurement · score 0.43
- smoking behavior · score 0.42
- lean body mass · score 0.42
- body fat percentage · score 0.41
- fat body mass · score 0.39
- serum alanine aminotransferase measurement · score 0.38
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P41161-F1 | alphafold | PREDICTED | 57.07 | — |
Amino-acid sequence (510 residues)
MDGFYDQQVP FMVPGKSRSE ECRGRPVIDR KRKFLDTDLA HDSEELFQDL SQLQEAWLAE AQVPDDEQFV PDFQSDNLVL HAPPPTKIKR ELHSPSSELS SCSHEQALGA NYGEKCLYNY CAYDRKPPSG FKPLTPPTTP LSPTHQNPLF PPPQATLPTS GHAPAAGPVQ GVGPAPAPHS LPEPGPQQQT FAVPRPPHQP LQMPKMMPEN QYPSEQRFQR QLSEPCHPFP PQPGVPGDNR PSYHRQMSEP IVPAAPPPPQ GFKQEYHDPL YEHGVPGMPG PPAHGFQSPM GIKQEPRDYC VDSEVPNCQS SYMRGGYFSS SHEGFSYEKD PRLYFDDTCV VPERLEGKVK QEPTMYREGP PYQRRGSLQL WQFLVTLLDD PANAHFIAWT GRGMEFKLIE PEEVARRWGI QKNRPAMNYD KLSRSLRYYY EKGIMQKVAG ERYVYKFVCD PDALFSMAFP DNQRPFLKAE SECHLSEEDT LPLTHFEDSP AYLLDMDRCS SLPYAEGFAY
Explore ETS translocation variant 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets